10 documents found, page 1 of 1

Health-related quality of life in older patients surviving ICU treatment for CO...

Funding: In addition, the study was supported by a grant from the European Open Science Cloud (EOSC). EOSCsecretariat.eu has received funding from the European Union’s Horizon Programme call H2020-INFRAEOSC-05-2018-2019, grant agreement number 831644. This work was supported by the Forschungskommission of the Medical Faculty of the Heinrich-Heine-University Düsseldorf, No. 2018-32 to G.W. and No. 2020-21 to R.R...

Disease-course adapting machine learning prognostication models in critically i...

Funding: he support of the study in France by a grant from Fondation Assistance Publique-Hôpitaux de Paris Pour la Recherche is greatly appreciated. In Norway, the study was supported by a grant from Health Region West. In addition, EOSCsecretariat.eu provided support and has received funding from the European Union’s Horizon Programme call H2020-INFRAEOSC-05-2018-2019, grant agreement number 831644. This work ...

Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critical...

Reliability of the Clinical Frailty Scale in very elderly ICU patients

PURPOSE: Frailty is a valuable predictor for outcome in elderly ICU patients, and has been suggested to be used in various decision-making processes prior to and during an ICU admission. There are many instruments developed to assess frailty, but few of them can be used in emergency situations. In this setting the clinical frailty scale (CFS) is frequently used. The present study is a sub-study within a larger ...

Steroid use in elderly critically ill COVID-19 patients

Funding Information: Support statement: This work was supported by the European Commission, APHP and Health Region West (Norway). Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Conflict of interest: C. Jung has nothing to disclose. B. Wernly has nothing to disclose. J. Fjølner has nothing to disclose. R.R. Bruno has nothing to disclose. D. Dudzins...

Management and outcomes in critically ill nonagenarian versus octogenarian pati...

Funding Information: This study was endorsed by the ESICM. Free support for running the electronic database and was granted from the dep. of Epidemiology, University of Aarhus, Denmark. Financial support for creation of the e-CRF and maintenance of the database was possible from a grant (open project support) by Western Health region in Norway) 2018 who also funded the participating Norwegian ICUs. DRC Ile de F...

Publisher Correction

In the original version of this Article, the VIP2 Study Group was incorrectly listed as an author in the author list. All members of the VIP2 Study Group are listed in the accompanying Supplementary Information file. The error has been corrected in the PDF and HTML versions of the Article, and in the Supplementary Information files.

Relationship between the Clinical Frailty Scale and short-term mortality in pat...

Funding Information: The members of VIP1 and VIP2 study groups are listed in Additional file 1 and are listed in their individual PubMed records. Publisher Copyright: © 2021, The Author(s). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.; Background: The Clinical Frailty Scale (CFS) is frequently used to measure frailty in critically ill adults. There is wide variation in the approach to analysing...

Sepsis at ICU admission does not decrease 30-day survival in very old patients

Background: The number of intensive care patients aged ≥ 80 years (Very old Intensive Care Patients; VIPs) is growing. VIPs have high mortality and morbidity and the benefits of ICU admission are frequently questioned. Sepsis incidence has risen in recent years and identification of outcomes is of considerable public importance. We aimed to determine whether VIPs admitted for sepsis had different outcomes than ...

Sex-specific outcome disparities in very old patients admitted to intensive car...

Female and male very elderly intensive patients (VIPs) might differ in characteristics and outcomes. We aimed to compare female versus male VIPs in a large, multinational collective of VIPs with regards to outcome and predictors of mortality. In total, 7555 patients were included in this analysis, 3973 (53%) male and 3582 (47%) female patients. The primary endpoint was 30-day-mortality. Baseline characteristics...